Last Updated on Nov 13, 2026

Hematology/ Oncology and Stem Cell Therapy- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Wolters Kluwer Health

Abbreviation: Hematol./ Oncol. Stem Cell Ther.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.32

SJR

 0.506

h-Index

 34

Rank

 11764

Important Details

Title Hematology/ Oncology and Stem Cell Therapy
Standard Abbreviation Hematol./ Oncol. Stem Cell Ther.
Type of Publication Journal
Discipline Hematology (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3)
Impact Score 1.32
SCImago Journal Rank (SJR) 0.506
h-index 34
Overall Rank 11764
Publisher Name Wolters Kluwer Health
Publication Country United Kingdom
International Standard Serial Number (ISSN) 25890646, 16583876
Coverage and History 2008-2025
Best Quartile Q3
Total Citations Received
(Last 3 Year)
197

About Hematology/ Oncology and Stem Cell Therapy


Hematology/ Oncology and Stem Cell Therapy is a journal published by Wolters Kluwer Health. This journal covers the area[s] related to Hematology, Medicine (miscellaneous), Oncology, etc. The coverage history of this journal is as follows: 2008-2025. The rank of this journal is 11764. This journal's impact score, h-index, and SJR are 1.32, 34, and 0.506, respectively. The ISSN of this journal is/are as follows: 25890646, 16583876.

The best quartile of Hematology/ Oncology and Stem Cell Therapy is Q3. This journal has received a total of 197 citations during the last three years (Preceding 2025).


Hematology/ Oncology and Stem Cell Therapy Impact Score 2025-2026


The latest impact score (IS) of the Hematology/ Oncology and Stem Cell Therapy is 1.32. It is computed in the year 2026 as per its definition and based on Scopus data. 1.32

It is decreased by a factor of around 0.18, and the percentage change is -12% compared to the preceding year 2024, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Hematology/ Oncology and Stem Cell Therapy Impact Score 2026


Impact Score 2025 of Hematology/ Oncology and Stem Cell Therapy is 1.32. If a similar downward trend continues, IS may decrease in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Hematology/ Oncology and Stem Cell Therapy. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 1.32
2024 1.50
2023 1.58
2022 1.87
2021 2.20
2020 1.72
2019 2.01
2018 1.16
2017 1.38
2016 1.37
2015 1.22
2014 0.77

Hematology/ Oncology and Stem Cell Therapy h-index


  Table Setting

The h-index of Hematology/ Oncology and Stem Cell Therapy is 34. By definition of the h-index, this journal has at least 34 published articles with more than 34 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Hematology/ Oncology and Stem Cell Therapy ISSN


The International Standard Serial Number (ISSN) of Hematology/ Oncology and Stem Cell Therapy is/are as follows: 25890646, 16583876.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Hematology/ Oncology and Stem Cell Therapy Ranking and SCImago Journal Rank (SJR)


The Hematology/ Oncology and Stem Cell Therapy is ranked 11764 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.506.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Hematology/ Oncology and Stem Cell Therapy Publisher


Table Setting

The publisher of Hematology/ Oncology and Stem Cell Therapy is Wolters Kluwer Health. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2008-2025.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Hematology/ Oncology and Stem Cell Therapy is Hematol./ Oncol. Stem Cell Ther.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Hematol./ Oncol. Stem Cell Ther.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Hematology/ Oncology and Stem Cell Therapy


If your area of research or discipline is related to Hematology, Medicine (miscellaneous), Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Hematology/ Oncology and Stem Cell Therapy?

The latest impact score of Hematology/ Oncology and Stem Cell Therapy is 1.32. It is computed in the year 2026.


What is the h-index of Hematology/ Oncology and Stem Cell Therapy?

The latest h-index of Hematology/ Oncology and Stem Cell Therapy is 34. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Hematology/ Oncology and Stem Cell Therapy?

The latest SCImago Journal Rank (SJR) of Hematology/ Oncology and Stem Cell Therapy is 0.506. It is calculated in the year 2026.


What is the ranking of Hematology/ Oncology and Stem Cell Therapy?

The latest ranking of Hematology/ Oncology and Stem Cell Therapy is 11764. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Hematology/ Oncology and Stem Cell Therapy?

Hematology/ Oncology and Stem Cell Therapy is published by Wolters Kluwer Health. The publication country of this journal is United Kingdom.


What is the abbreviation of Hematology/ Oncology and Stem Cell Therapy?

This standard abbreviation of Hematology/ Oncology and Stem Cell Therapy is Hematol./ Oncol. Stem Cell Ther..


Is "Hematology/ Oncology and Stem Cell Therapy" a Journal, Conference or Book Series?

Hematology/ Oncology and Stem Cell Therapy is a journal published by Wolters Kluwer Health.


What is the scope of Hematology/ Oncology and Stem Cell Therapy?

The scope of Hematology/ Oncology and Stem Cell Therapy is as follows:

  • Hematology
  • Medicine (miscellaneous)
  • Oncology

For detailed scope of Hematology/ Oncology and Stem Cell Therapy, check the official website of this journal.


What is the ISSN of Hematology/ Oncology and Stem Cell Therapy?

The International Standard Serial Number (ISSN) of Hematology/ Oncology and Stem Cell Therapy is/are as follows: 25890646, 16583876.


What is the best quartile for Hematology/ Oncology and Stem Cell Therapy?

The best quartile for Hematology/ Oncology and Stem Cell Therapy is Q3.


What is the coverage history of Hematology/ Oncology and Stem Cell Therapy?

The coverage history of Hematology/ Oncology and Stem Cell Therapy is as follows 2008-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Istanbul University - Journal of Electrical and Electronics Engineering Journal University of Istanbul 24654 0 0.00
Child and Family Social Work Journal Wiley-Blackwell Publishing Ltd 8813 81 2.26
International Journal of Parallel, Emergent and Distributed Systems Journal Taylor and Francis Ltd. 19086 29 1.26
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute Journal Hoikkaido Forest Products Research Institute 28000 5 0.09
Museum Management and Curatorship Journal Routledge 9596 47 2.48
Canadian Journal of Mathematics Journal Cambridge University Press 7644 50 0.79
Consulting engineer Barrington Journal Cahners Pub. Co. 24079 0 0.00
Brazilian Symposium of Computer Graphic and Image Processing Conference And Proceedings IEEE Computer Society 24165 35 0.64
Chemical Product and Process Modeling Journal Walter de Gruyter GmbH 18165 24 1.61

Check complete list




Hematology/ Oncology and Stem Cell Therapy Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 1.32
2024 1.50
2023 1.58
2022 1.87
2021 2.20
2020 1.72
2019 2.01
2018 1.16
2017 1.38
2016 1.37
2015 1.22
2014 0.77



Top Journals/Conferences in Hematology

BMC Hematology
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

See All

Top Journals/Conferences in Medicine (miscellaneous)

Wiley Interdisciplinary Reviews: Systems Biology and Medicine
John Wiley & Sons Inc. | United States

MicroRNA (Shariqah, United Arab Emirates)
Bentham Science Publishers B.V. | United Arab Emirates

Alcoholism: Clinical and Experimental Research
Wiley-Blackwell | United States

ADHD Attention Deficit and Hyperactivity Disorders
Springer-Verlag Wien | Austria

Clinical Research in Cardiology Supplements
Springer Verlag | Germany

Rural policy brief
Rural Policy Research Institute | United States

Female Pelvic Medicine and Reconstructive Surgery
Lippincott Williams and Wilkins Ltd. | United States

Journal of studies on alcohol and drugs. Supplement
Alcohol Research Documentation, Inc. | United States

Journal of investigative and clinical dentistry
Wiley-Blackwell | United States

Global Advances In Health and Medicine
SAGE Publications Inc. | United States

Progress in molecular and subcellular biology
Springer Verlag | Germany

Seminars in Cutaneous Medicine and Surgery
Frontline Medical Communications Inc. | United States

Progress in the chemistry of organic natural products
Springer Verlag | Germany

Hospital practice (1995)
Taylor and Francis Ltd. | United Kingdom

Experientia supplementum (2012)
Springer International Publishing AG | Switzerland

See All

Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All